{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:37:03Z","timestamp":1772555823020,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clbc.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T21:13:07Z","timestamp":1652908387000},"page":"507-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-1681","authenticated-orcid":false,"given":"RamaRao","family":"Malla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Puvalachetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul K.","family":"Vempati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakshmitha","family":"Marni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-203X","authenticated-orcid":false,"given":"Neha","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-5234","authenticated-orcid":false,"given":"Ganji Purnachandra","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.05.004_bib0001","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-20-1799","article-title":"Phenotypic heterogeneity and metastasis of breast cancer cells","volume":"81","author":"Hapach","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.clbc.2022.05.004_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4331\/wjbc.v12.i2.15","article-title":"Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy","volume":"12","author":"Malla","year":"2021","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.clbc.2022.05.004_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","article-title":"Molecular classification of breast cancer: A retrospective cohort study","volume":"49","author":"Al-thoubaity","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.clbc.2022.05.004_bib0004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djz208","article-title":"Unraveling triple-negative breast cancer tumor microenvironment heterogeneity:towards an optimized treatment approach","volume":"112","author":"Bareche","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2022.05.004_bib0005","doi-asserted-by":"crossref","first-page":"41717","DOI":"10.18632\/oncotarget.16684","article-title":"Exosome: emerging biomarker in breast cancer","volume":"8","author":"Jia","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2022.05.004_bib0006","first-page":"108","article-title":"CTC enumeration and characterization: moving toward personalized medicine","volume":"2","author":"Toss","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clbc.2022.05.004_bib0007","first-page":"437","article-title":"Circulating cancer stem cells: the importance to select","volume":"27","author":"Yang","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/9\/1\/016003","article-title":"Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers","volume":"9","author":"Marrinucci","year":"2012","journal-title":"Phys Biol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0009","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0010","first-page":"72","article-title":"Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells","volume":"36","author":"Bezdenezhnykh","year":"2014","journal-title":"Exp Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0011","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4049\/jimmunol.166.5.3506","article-title":"Integrin \u03b1E (CD103) \u03b27 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interaction","volume":"166","author":"Strauch","year":"2001","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.clbc.2022.05.004_bib0012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yexmp.2017.02.013","article-title":"In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer","volume":"102","author":"Alkatout","year":"2017","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152729","article-title":"Tumor microenvironment components: Allies of cancer progression","volume":"216","author":"Ribeiro Franco","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.clbc.2022.05.004_bib0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-019-0988-0","article-title":"MCT-1\/miR-34a\/IL-6\/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer","volume":"18","author":"Weng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biopha.2016.02.044","article-title":"The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment","volume":"80","author":"Gao","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clbc.2022.05.004_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41598-017-17913-x","article-title":"LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer","volume":"8","author":"Boulding","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2022.05.004_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-021-01112-9","article-title":"Involvement of immune system and Epithelial\u2013Mesenchymal-Transition in increased invasiveness of clustered circulatory tumor cells in breast cancer","volume":"14","author":"Khoshbakht","year":"2021","journal-title":"BMC medical genomics"},{"key":"10.1016\/j.clbc.2022.05.004_bib0018","first-page":"1889","article-title":"Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells","volume":"9","author":"Huang","year":"2019","journal-title":"Am.J .Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.clbc.2022.05.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol . Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0021","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/annonc\/mdu018","article-title":"Circulating tumor cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research","volume":"25","author":"Grover","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0022","series-title":"The Tumor Microenvironment At A Glance","author":"Balkwill","year":"2012"},{"key":"10.1016\/j.clbc.2022.05.004_bib0023","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-019-0973-7","article-title":"Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1878-0261.12022","article-title":"Circulating and disseminated tumor cells: harbingers or initiators of metastasis?","volume":"11","author":"Dasgupta","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0025","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1038\/s41388-018-0391-0","article-title":"Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer","volume":"37","author":"Fu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2022.05.004_bib0026","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molonc.2016.01.010","article-title":"Clinical and biological significance of circulating tumor cells in cancer","volume":"10","author":"Masuda","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2009.06.027","article-title":"Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer","volume":"288","author":"Theodoropoulos","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2022.05.004_bib0028","first-page":"1641","article-title":"A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer","volume":"58","author":"Wang","year":"2012","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000337106","article-title":"Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells","volume":"79","author":"Ksi\u0105\u017ckiewicz","year":"2012","journal-title":"Pathobiology"},{"key":"10.1016\/j.clbc.2022.05.004_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbcan.2012.12.002","article-title":"Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications","volume":"1835","author":"Scatena","year":"2013","journal-title":"Biochim Biophys Acta - Reviews on Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0031","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fmolb.2020.00134","article-title":"Circulating tumorcells in metastatic breast cancer: from genome instability to metastasis","volume":"7","author":"Ivanova","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clbc.2022.05.004_bib0032","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/ijc.32820","article-title":"Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery","volume":"146","author":"Raskov","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0033","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms20081916","article-title":"PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/Notch\/Nodal signaling","volume":"20","author":"Sprouse","year":"2019","journal-title":"Int.J. Mol. Sci"},{"key":"10.1016\/j.clbc.2022.05.004_bib0034","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2022.05.004_bib0035","doi-asserted-by":"crossref","first-page":"35656","DOI":"10.18632\/oncotarget.10290","article-title":"Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer","volume":"8","author":"Mego","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2022.05.004_bib0036","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cancers12020376","article-title":"Clinical relevance of immune checkpoints on circulating tumor cells in breast cancer","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2022.05.004_bib0037","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yexmp.2013.06.013","article-title":"Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment","volume":"95","author":"Green","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0038","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.yexmp.2014.04.001","article-title":"Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells","volume":"96","author":"Santos","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0039","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/cancers12102861","article-title":"Dangerous liaisons: circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs)","volume":"12","author":"Hurtado","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2022.05.004_bib0040","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900425","article-title":"Stromal fibroblasts induce metastatic tumor cell clusters via epithelial\u2013mesenchymal plasticity","volume":"2","author":"Matsumura","year":"2019","journal-title":"Life Science Alliance"},{"key":"10.1016\/j.clbc.2022.05.004_bib0041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.critrevonc.2015.10.010","article-title":"Circulating tumor cells in breast cancer\u2013current status and perspectives","volume":"97","author":"Banys-Paluchowski","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0042","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.apsb.2021.04.009","article-title":"Cancer-specific calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced anti-metastasis combinational chemotherapy","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.clbc.2022.05.004_bib0043","article-title":"Zileuton loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells","volume":"24","author":"Gener","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.clbc.2022.05.004_bib0044","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.clbc.2022.05.004_bib0045","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/cells9092129","article-title":"High sensitivity of circulating tumor cells derived from a colorectal cancer patient for dual inhibition with AKT and mTOR inhibitors","volume":"9","author":"Smit","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.clbc.2022.05.004_bib0046","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jtcvs.2005.10.060","article-title":"Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer","volume":"132","author":"Backhus","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clbc.2022.05.004_bib0047","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/ijc.31238","article-title":"RhoA-stimulated intra-capillary morphology switch facilitates the arrest of individual circulating tumor cells","volume":"142","author":"Huang","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0048","first-page":"1","article-title":"Novel approaches in cancer management with circulating tumor cell clusters","volume":"4","author":"Rostami","year":"2019","journal-title":"Journal of Science: Adv Mater Devices"},{"key":"10.1016\/j.clbc.2022.05.004_bib0049","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2015.12.002","article-title":"Challenges in circulating tumor cell detection by the CellSearch system","volume":"10","author":"Andree","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0050","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cyto.a.23571","article-title":"The Parsortix cell separation system-a versatile liquid biopsy platform","volume":"93","author":"Miller","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.clbc.2022.05.004_bib0051","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/14737159.2015.1032260","article-title":"Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis","volume":"15","author":"Pachmann","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.clbc.2022.05.004_bib0052","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.3390\/ijms20163884","article-title":"The role of exosomal microRNAs in the tumor microenvironment of breast cancer","volume":"20","author":"Liu","year":"2019","journal-title":"Int.J. Mol. Sci"},{"key":"10.1016\/j.clbc.2022.05.004_bib0053","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-020-01318-0","article-title":"Tumor-derived exosomes in the regulation of macrophage polarization","volume":"69","author":"Baig","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0054","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3389\/fimmu.2018.00871","article-title":"Breast cancer-derived exosomes alter macrophage polarization via gp130\/STAT3 signaling","volume":"9","author":"Ham","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0055","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","article-title":"Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration","volume":"151","author":"Luga","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2022.05.004_bib0056","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.omtn.2019.11.024","article-title":"MicroRNA-181d-5p-containing exosomes derived from CAFs Promote EMT by regulating CDX2\/HOXA5 in breast cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.clbc.2022.05.004_bib0057","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1158\/0008-5472.CAN-16-0868","article-title":"The biodistribution and immune suppressive effects of breast cancer-derivedexosomes","volume":"76","author":"Wen","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0058","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/fimmu.2020.02026","article-title":"Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92\/PD-L1 pathway","volume":"11","author":"Dou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0059","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","article-title":"Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells","volume":"5","author":"Ni","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.clbc.2022.05.004_bib0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tips.2016.04.006","article-title":"Exosome-mediated metastasis: from epithelial-mesenchymal transition to escape from immunosurveillance","volume":"37","author":"Syn","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clbc.2022.05.004_bib0061","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1002\/jcp.27740","article-title":"Cancer stem cells (CSCs) in cancer progression and therapy","volume":"234","author":"Najafi","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0062","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1541-7786.MCR-17-0539","article-title":"Multigene profiling of CTCs in mCRPC identifies a clinicallyrelevant prognostic signature","volume":"16","author":"Singhal","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0063","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/cells10010123","article-title":"Hedgehog signaling, a critical pathway governing the development and progression of hepatocellular carcinoma","volume":"10","author":"Ding","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clbc.2022.05.004_bib0064","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1158\/0008-5472.CAN-20-0212","article-title":"YAP Enhances tumor cell dissemination by promoting intravascular motility and reentry into systemic circulation","volume":"80","author":"Benjamin","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0065","first-page":"871","article-title":"The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer","volume":"29","author":"Kameda","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0066","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13058-014-0444-4","article-title":"Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF\u03baB) pathway","volume":"16","author":"Colavito","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0067","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fgene.2019.00556","article-title":"Non-canonical hedgehog signaling pathway in cancer: activation of GLI transcription factors beyond smoothened","volume":"10","author":"Pietrobono","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.clbc.2022.05.004_bib0068","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/cancers11081126","article-title":"The hedgehog signaling pathway: A viable target in breast cancer?","volume":"11","author":"Bhateja","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2022.05.004_bib0069","doi-asserted-by":"crossref","first-page":"80","DOI":"10.17140\/CSMMOJ-2-112","article-title":"Activation of inflammatory responses correlate with hedgehog activation and precede expansion of cancer stem-like cells in an animal model of residual triple negative breast cancer after neoadjuvant chemotherapy","volume":"2","author":"Arnold","year":"2015","journal-title":"Cancer Stud Mol Med"},{"key":"10.1016\/j.clbc.2022.05.004_bib0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13046-018-0925-x","article-title":"HIF-2\u03b1 promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways","volume":"37","author":"Yan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0071","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/s41388-019-0700-2","article-title":"WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer","volume":"38","author":"Castagnoli","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2022.05.004_bib0072","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ncb3613","article-title":"Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1","volume":"19","author":"Zhuang","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0073","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41467-019-12807-0","article-title":"Microenvironmental IL1\u03b2 promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling","volume":"10","author":"Eyre","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2022.05.004_bib0074","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1021\/acsbiomaterials.9b00923","article-title":"Wnt\/\u03b2-Catenin signaling pathway regulates osteogenesis for breast cancer bone metastasis: experiments in an in vitro nanoclay scaffold cancer testbed","volume":"6","author":"Kar","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.clbc.2022.05.004_bib0075","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3389\/fimmu.2019.02293","article-title":"WNT\/\u03b2-Catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0076","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin.Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0077","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","article-title":"The Hippo pathway in intestinal regeneration and disease","volume":"13","author":"Hong","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clbc.2022.05.004_bib0078","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/abbs\/gmu114","article-title":"Hippo pathway in mammary gland development and breast cancer","volume":"47","author":"Shi","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.clbc.2022.05.004_bib0079","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2015.12.004","article-title":"Hippo pathway and breast cancer stem cells","volume":"99","author":"Maugeri-Sacc\u00e0","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.clbc.2022.05.004_bib0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","article-title":"OTUB2 Promotes cancer metastasis via Hippo-independent activation of YAP and TAZ","volume":"73","author":"Zhang","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.clbc.2022.05.004_bib0081","first-page":"83","article-title":"The role of Hippo pathway in cancer stem cell biology","volume":"41","author":"Park","year":"2018","journal-title":"Mol Cells"},{"key":"10.1016\/j.clbc.2022.05.004_bib0082","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","article-title":"The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells","volume":"147","author":"Cordenonsi","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2022.05.004_bib0083","doi-asserted-by":"crossref","first-page":"11691","DOI":"10.2147\/OTT.S236607","article-title":"miR-520b Promotes breast cancer stemness through Hippo\/YAP signaling pathway","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clbc.2022.05.004_bib0084","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-020-2725-4","article-title":"Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clbc.2022.05.004_bib0085","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-19-0012","article-title":"Glucocorticoid receptor signaling activates TEAD4 to promote breast cancer progression","volume":"79","author":"He","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2022.05.004_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108349","article-title":"FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner","volume":"685","author":"Sun","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.clbc.2022.05.004_bib0087","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature20829","article-title":"The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ER\u03b1","volume":"541","author":"Britschgi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2022.05.004_bib0088","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7938280","article-title":"The prospect of identifying resistance mechanisms for castrateresistant prostate cancer using circulating tumor cells: Is epithelial-to-mesenchymal transition a key player?","volume":"2020","author":"Khan","year":"2020","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0089","first-page":"8374","article-title":"Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis","volume":"22","author":"Li","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clbc.2022.05.004_bib0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1186\/s12885-020-07275-5","article-title":"Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0091","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bjc.6605486","article-title":"Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion","volume":"102","author":"Chen","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clbc.2022.05.004_bib0092","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.gendis.2020.11.015","article-title":"Tumor microenvironment pathways: Cross regulation in breast cancer metastasis","volume":"9","author":"Malla","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.clbc.2022.05.004_bib0093","doi-asserted-by":"crossref","first-page":"22390","DOI":"10.3402\/jev.v2i0.22390","article-title":"Cancer becomes wasteful: emerging roles of exosomes(\u2020) in cell-fate determination","volume":"2","author":"Wendler","year":"2013","journal-title":"J Extracell Vesicles"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:57Z","timestamp":1761513837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1526820922000945"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.05.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}